# New Super Antibiotic EVG7 Eliminates Deadly Gut Infection at 1/10th the Dose While Sparing Beneficial Bacteria

*2026-03-13 03:02 UTC · Science · 1 min read*

> Leiden University scientists created EVG7, a super antibiotic 16x more potent than vancomycin against C. difficile that preserves gut microbiome.

Researchers at Leiden University have developed EVG7, a next-generation antibiotic that eliminates Clostridioides difficile — a dangerous gut bacterium notorious for recurring after treatment — using just a fraction of the dose needed by current drugs. Clinical isolates are up to 16 times more sensitive to EVG7 than to vancomycin, the current standard treatment.

In mouse trials, low-dose EVG7 outperformed vancomycin given at 10 times the concentration, both in clearing primary infections and preventing relapse. Crucially, EVG7 spares Lachnospiraceae, a family of beneficial gut bacteria that naturally suppresses C. difficile colonization. "That approach fits a growing trend among doctors to preserve the microbiome as much as possible," said lead author Elma Mons.

The study, published in Nature Communications, also found no signs of antibiotic resistance developing against EVG7, addressing one of the biggest challenges in modern medicine.

## Sources

- [sciencedaily.com](https://www.sciencedaily.com/releases/2026/03/260311004824.htm)
- [nature.com](https://www.nature.com/articles/s41467-025-64067-w)

---
TechTools News · https://techtools.cz/tools/news/article/759-new-super-antibiotic-evg7-eliminates-deadly-gut-infection-at-1-10th-the-dose
Česká verze: https://techtools.cz/tools/news/clanek/778-nove-superantibiotikum-evg7-nici-smrtelnou-strevni-infekci-pri-desetine-davky-a
